Clinical Trial Update: A Study of RAY1225 in Participants With Obesity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating RAY1225 in individuals with obesity is currently recruiting. The study is sponsored by Guangdong Raynovent Biotech Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• RAY1225

Snippet

Sponsor: Guangdong Raynovent Biotech Co., Ltd | Conditions: Obesity | Phase 2 | Status: RECRUITING